80 FR 53272 - Contact Lens Rule

FEDERAL TRADE COMMISSION

Federal Register Volume 80, Issue 171 (September 3, 2015)

Page Range		53272-53274
FR Document		2015-21577

The Commission is requesting public comments on the Contact Lens Rule, which requires that eyecare prescribers provide a copy of a consumer's prescription to the consumer upon completion of a contact lens fitting and verify or provide prescriptions to authorized third parties. The Rule also mandates that a contact lens seller may sell contact lenses only in accordance with a prescription that the seller either: (a) Has received from the patient or prescriber; or (b) has verified through direct communication with the prescriber. The Commission is soliciting comments about the efficiency, costs, benefits, and regulatory impact of the Rule as part of its systematic review of all current Commission regulations and guides. All interested persons are hereby given notice of the opportunity to submit written data, views, and arguments concerning the Rule.

Federal Register, Volume 80 Issue 171 (Thursday, September 3, 2015)

[Federal Register Volume 80, Number 171 (Thursday, September 3, 2015)]
[Proposed Rules]
[Pages 53272-53274]
From the Federal Register Online [www.thefederalregister.org]
[FR Doc No: 2015-21577]

=======================================================================
-----------------------------------------------------------------------

FEDERAL TRADE COMMISSION

16 CFR Part 315

Contact Lens Rule

AGENCY: Federal Trade Commission (``FTC'' or ``Commission'').

ACTION: Request for comment.

-----------------------------------------------------------------------

SUMMARY: The Commission is requesting public comments on the Contact
Lens Rule, which requires that eyecare prescribers provide a copy of a
consumer's prescription to the consumer upon completion of a contact
lens fitting and verify or provide prescriptions to authorized third
parties. The Rule also mandates that a contact lens seller may sell
contact lenses only in accordance with a prescription that the seller
either: (a) Has received from the patient or prescriber; or (b) has
verified through direct communication with the prescriber. The
Commission is soliciting comments about the efficiency, costs,
benefits, and regulatory impact of the Rule as part of its systematic
review of all current Commission regulations and guides. All interested
persons are hereby given notice of the opportunity to submit written
data, views, and arguments concerning the Rule.

DATES: Written comments must be received on or before October 26, 2015.

ADDRESSES: Interested parties may file a comment at https://ftcpublic.commentworks.com/ftc/contactlensrule online or on paper, by
following the instructions in the Instructions for Submitting Comments
part of the SUPPLEMENTARY INFORMATION section below. Write ``Contact
Lens Rule, 16 CFR part 315, Project No. R511995'' on your comment, and
file your comment online at https://ftcpublic.commentworks.com/ftc/contactlensrule by following the instructions on the web-based form. If
you prefer to file your comment on paper, write ``Contact Lens Rule, 16
CFR

[[Page 53273]]

part 315, Project No. R511995'' on your comment and on the envelope and
mail your comment to the following address: Federal Trade Commission,
Office of the Secretary, 600 Pennsylvania Avenue NW., Suite CC-5610
(Annex C), Washington, DC 20580, or deliver your comment to the
following address: Federal Trade Commission, Office of the Secretary,
Constitution Center, 400 7th Street SW., 5th Floor, Suite 5610 (Annex
C), Washington, DC 20024.

FOR FURTHER INFORMATION CONTACT: Alysa Bernstein, Attorney, (202) 326-
3289, or Bonnie McGregor, Federal Trade Investigator, (202) 326-2356,
Division of Advertising Practices, Bureau of Consumer Protection,
Federal Trade Commission, 600 Pennsylvania Avenue NW., Washington, DC
20580.

SUPPLEMENTARY INFORMATION:

I. Background

In 2003, Congress enacted The Fairness to Contact Lens Consumers
Act, 15 U.S.C. 7601-7610, and pursuant to the Act, the Commission
promulgated the Contact Lens Rule on July 2, 2004.\1\ The Rule went
into effect on August 2, 2004.
---------------------------------------------------------------------------

\1\ Contact Lens Rule, 16 CFR part 315.
---------------------------------------------------------------------------

The Contact Lens Rule is intended to facilitate the ability of
consumers to comparison shop for contact lenses while ensuring that
contact lenses are sold only in accordance with a valid prescription.
The Rule requires that eyecare prescribers provide a copy of a
prescription to the consumer upon completion of a contact lens fitting
and verify or provide prescriptions to authorized third parties.\2\
---------------------------------------------------------------------------

\2\ 16 CFR 315.3(a).
---------------------------------------------------------------------------

The Rule specifies that a prescriber may not require the purchase
of contact lenses as a condition of providing the prescription or
verification, may not require payment in addition to, or as a part of,
the fee for an eye examination, fitting, and evaluation as a condition
of providing the prescription or verification, and may not require the
patient to sign a waiver or release as a condition of releasing or
verifying the prescription.\3\ The prescriber is also prohibited from
requiring immediate payment before the release of a prescription,
unless the prescriber requires immediate payment when an exam reveals
that the consumer does not need ophthalmic goods.\4\
---------------------------------------------------------------------------

\3\ 16 CFR 315.3(b).
\4\ 16 CFR 315.4.
---------------------------------------------------------------------------

The Rule also places certain restrictions on sellers. It mandates
that sellers sell contact lenses only in accordance with a prescription
that is either presented to the seller or verified by direct
communication with the prescriber.\5\ The Rule sets out the information
that must be included in a seller's verification request, and directs
that a prescription is only verified under the Rule if: (1) A
prescriber confirms the prescription is accurate, (2) a prescriber
informs the seller that the prescription is inaccurate and provides an
accurate prescription, or (3) if the prescriber fails to communicate
with the seller within eight business hours after receiving a compliant
verification request.\6\ The Rule states that if the prescriber informs
the seller within eight hours of receiving the verification request
that the prescription is inaccurate, expired, or invalid, the seller
shall not fill the prescription.\7\
---------------------------------------------------------------------------

\5\ 16 CFR 315.5(a).
\6\ 16 CFR 315.5(b)-(c).
\7\ 16 CFR 315.5(d). If the prescription communicated by the
seller is inaccurate, the prescriber shall correct it. Id.
---------------------------------------------------------------------------

Sellers may not alter a prescription, but for private label contact
lenses, may substitute identical contact lenses that the same company
manufactures and sells under a different name.\8\ Sellers and others
involved in the manufacture, assembly, processing and distribution of
contact lenses are prohibited from representing that contact lenses may
be obtained without a prescription.\9\
---------------------------------------------------------------------------

\8\ 16 CFR 315.5(e).
\9\ 16 CFR 315.7.
---------------------------------------------------------------------------

The Contact Lens Rule sets a minimum expiration date of one year
after the issue date of a prescription with an exception based on a
patient's ocular health.\10\ The Rule also implements the Act by
providing that ``state and local laws and regulations that establish a
prescription expiration date of less than one year or that restrict
prescription release or require active verification are pre-empted.''
\11\
---------------------------------------------------------------------------

\10\ 16 CFR 315.6.
\11\ 16 CFR 315.11(a). The Rule states further that ``[a]ny
other state or local laws or regulations that are inconsistent with
the Act or this part are prempted to the extent of the
inconsistency.'' 16 CFR 315.11(b).
---------------------------------------------------------------------------

II. Regulatory Review of the Contact Lens Rule

The Commission periodically reviews all of its rules and guides.
These reviews seek information about the costs and benefits of the
agency's rules and guides, and their regulatory and economic impact.
The information obtained assists the Commission in identifying those
rules and guides that warrant modification or rescission. Therefore,
the Commission solicits comments on, among other things, the economic
impact and benefits of the Rule; possible conflict between the Rule and
State, local, or other Federal laws or regulations; and the effect on
the Rule of any technological, economic, or other industry changes
since the Rule was promulgated.

III. Issues for Comment

The Commission requests written comment on any or all of the
following questions. These questions are designed to assist the public
and should not be construed as a limitation on the issues on which
public comment may be submitted. The Commission requests that responses
to its questions be as specific as possible, including a reference to
the question being answered, and reference to empirical data or other
evidence upon which comments are based wherever available and
appropriate.
1. Is there a continuing need for the Rule? Why or why not?
2. What benefits has the Rule provided to consumers? What evidence
supports the asserted benefits?
3. What modifications, if any, should be made to the Rule to
increase its benefits to consumers?
a. What evidence supports the proposed modifications?
b. How would these modifications affect the costs the Rule imposes
on businesses, including small businesses?
c. How would these modifications affect the benefits to consumers?
4. What impact has the Rule had on the flow of truthful information
to consumers and on the flow of deceptive information to consumers?
5. What significant costs, if any, has the Rule imposed on
consumers? What evidence supports the asserted costs?
6. What modifications, if any, should be made to the Rule to reduce
any costs imposed on consumers?
a. What evidence supports the proposed modifications?
b. How would these modifications affect the benefits provided by
the Rule?
7. What benefits, if any, has the Rule provided to businesses,
including small businesses? What evidence supports the asserted
benefits?
8. What modifications, if any, should be made to the Rule to
increase its benefits to businesses, including small businesses?
a. What evidence supports the proposed modifications?
b. How would these modifications affect the costs the Rule imposes
on businesses, including small businesses?
c. How would these modifications affect the benefits to consumers?
9. What significant costs, if any, including costs of compliance,
has the Rule imposed on businesses, including small businesses? What
evidence supports the asserted costs?

[[Page 53274]]

10. What modifications, if any, should be made to the Rule to
reduce the costs imposed on businesses, including small businesses?
a. What evidence supports the proposed modifications?
b. How would these modifications affect the benefits provided by
the Rule?
11. What evidence is available concerning the degree of industry
compliance with the Rule?
12. What modifications, if any, should be made to the Rule to
account for changes in relevant technology or economic conditions? What
evidence supports the proposed modifications?
13. Does the Rule overlap or conflict with other federal, state, or
local laws or regulations? If so, how?
a. What evidence supports the asserted conflicts?
b. With reference to the asserted conflicts, should the Rule be
modified? If so, why, and how? If not, why not?

IV. Instructions for Submitting Comments

You can file a comment online or on paper. For the Commission to
consider your comment, we must receive it on or before October 26,
2015. Write ``Contact Lens Rule, 16 CFR part 315, Project No. R511995''
on the comment. Your comment, including your name and your state, will
be placed on the public record of this proceeding, including, to the
extent practicable, on the public Commission Web site, at http://www.ftc.gov/os/publiccomments.shtm. As a matter of discretion, the
Commission tries to remove individuals' home contact information from
comments before placing them on the Commission Web site. Because your
comment will be made public, you are solely responsible for making sure
that your comment does not include any sensitive personal information,
such as a Social Security number, date of birth, driver's license
number or other state identification number or foreign country
equivalent, passport number, financial account number, or credit or
debit card number. You are also solely responsible for making sure that
your comment does not include any sensitive health information, such as
medical records or other individually identifiable health information.
In addition, do not include any ``[t]rade secret or any commercial
or financial information which is . . . privileged or confidential,''
as discussed in Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC
Rule 4.10(a)(2), 16 CFR 4.10(a)(2). In particular, do not include
competitively sensitive information such as costs, sales statistics,
inventories, formulas, patterns, devices, manufacturing processes, or
customer names.
If you want the Commission to give your comment confidential
treatment, you must file it in paper form, with a request for
confidential treatment, and you must follow the procedure explained in
FTC Rule 4.9(c), 16 CFR 4.9(c). In particular, the written request for
confidential treatment that accompanies the comment must include the
factual and legal basis for the request, and must identify the specific
portions of the comments to be withheld from the public record. Your
comment will be kept confidential only if the FTC General Counsel, in
his or her sole discretion, grants your request in accordance with the
law and the public interest.
Postal mail addressed to the Commission is subject to delay due to
heightened security screening. As a result, we encourage you to submit
your comment online. To make sure that the Commission considers your
online comment, you must file it at https://ftcpublic.commentworks.com/ftc/contactlensrule by following the instructions on the web-based
form. If this document appears at http://www.regulations.gov/#!home,
you also may file a comment through that Web site.
If you file your comment on paper, write ``Contact Lens Rule, 16
CFR part 315, Project No. R511995'' on your comment and on the
envelope, and mail your comment to the following address: Federal Trade
Commission, Office of the Secretary, 600 Pennsylvania Avenue NW., Suite
CC-5610 (Annex C), Washington, DC 20580, or deliver your comment to the
following address: Federal Trade Commission, Office of the Secretary,
Constitution Center, 400 7th Street SW., 5th Floor, Suite 5610 (Annex
C), Washington, DC 20024.
Visit the Commission Web site at http://www.ftc.gov to read this
document and the news release describing it. The FTC Act and other laws
that the Commission administers permit the collection of public
comments to consider and use in this proceeding as appropriate. The
Commission will consider all timely and responsive public comments that
it receives on or before October 26, 2015. You can find more
information, including routine uses permitted by the Privacy Act, in
the Commission's privacy policy, at http://www.ftc.gov/ftc/privacy.htm.

By direction of the Commission.
Donald S. Clark
Secretary.
[FR Doc. 2015-21577 Filed 9-2-15; 8:45 am]
BILLING CODE 6750-01-P

53272 Federal Register / Vol. 80, No. 171 / Thursday, September 3, 2015 / Proposed Rules

ADAMS Accession Number/Federal Register
Document Citation/URL

Federal Register notice—PRM–51–29, Commonwealth of Massachusetts, Supplemental Infor- 77 FR 76952.
mation, December 31, 2012.
Federal Register notice—Revisions to Environmental Review of Renewal of Nuclear Power 78 FR 37282.
Plant Operating Licenses Final Rule, June 20, 2013.
Generic Environmental Impact Statement for License Renewal of Nuclear Plants, NUREG– ML13107A023.
1437, Revision 1 (Volumes 1–3), June 21, 2013.
LBP–11–35, Memorandum and Order, denial of waiver in Pilgrim adjudicatory proceeding, De- ML11332A152.
cember 13, 2011.
NEI 06–12, ‘‘B.5.b Phases 2 & 3 Submittal Guideline, Revision 2,’’ Project 689, December 14, ML070090060.
2006.
NRC Overview of the Structural Integrity of the Spent Fuel Pool at Fukushima Dai-ichi, Unit 4, ML14111A099.
April 25, 2014.
NUREG–1353, ‘‘Regulatory Analysis for the Resolution of Generic Issue 82, ‘Beyond Design ML082330232.
Basis Accidents in Spent Fuel Pools,’ ’’ April 30, 1989.
NUREG–1437, ‘‘Generic Environmental Impact Statement for License Renewal of Nuclear ML13107A023.
Plants’’ (2013 GEIS), June 20, 2013.
NUREG–1437, ‘‘Generic Environmental Impact Statement for License Renewal of Nuclear ML040690705, ML040690738.
Plants’’ (1996 GEIS; Volumes 1 and 2), May 31, 1996.
NUREG–1738, ‘‘Technical Study of Spent Fuel Pool Accident Risk at Decommissioning Nu- ML010430066.
clear Power Plants,’’ S102686, February 28, 2001.
NUREG–2157, ‘‘Generic Environmental Impact Statement for Continued Storage of Spent Nu- ML14196A105, ML14196A107.
clear Fuel’’.
NUREG–2161, ‘‘Consequence Study of a Beyond-Design-Basis Earthquake Affecting the Spent ML14255A365.
Fuel Pool for a U.S. Mark I Boiling-Water Reactor’’ (Spent Fuel Pool Study), October 9, 2013.
Order EA–12–049, NRC Order on Mitigating Strategies, March 12, 2012 .................................... ML12054A735.
Order EA–12–051, NRC Order on Spent Fuel Pool Instrumentation, March 12, 2012 ................. ML12056A044.
Order EA–13–109, NRC Order on Severe Accident Capable Hardened Vents, June 6, 2013 ..... ML13143A321.
PRM–51–10, Commonwealth of Massachusetts, August 25, 2006 ............................................... ML062640409.
PRM–51–29, from Mathew Brock, Commonwealth Of Mass. Petition for Waiver of C.F.R. Part ML12254A005.
51 Subpart A, Appendix B or In Alternative Petition For Rulemaking to Rescind Regulations
Excluding Consideration Of Spent Fuel Storage Impacts, June 2, 2011.
Regulatory Guide 4.2, Supplement 1, Revision 1, ‘‘Preparation of Environmental Reports for ML13067A354.
Nuclear Power Plant License Renewal Applications,’’ June 20, 2013.
Report of Japanese Government to the IAEA Ministerial Conference on Nuclear Safety—The http://www.kantei.go.jp/foreign/kan/topics/
Accident at TEPCO’s Fukushima Nuclear Power Stations, June 2011. 201106/iaea_houkokusho_e.html.
Sandia Letter Report, Revision 2, Mitigation of Spent Fuel Pool Loss-of-Coolant Inventory Acci- ML120970086.
dents And Extension of Reference Plant Analyses to Other Spent Fuel Pools, November 30,
2006.
Sandia Report: MELCOR 1.8.5 Separate Effect Analysis of Spent Fuel Assembly Accident Re- ML062290362.
sponse, June 30, 2003.
SECY–04–0191, ‘‘Withholding Sensitive Unclassified Information Concerning Nuclear Power ML042310663.
Reactors From Public Disclosure,’’ October 19, 2004.
SECY–11–0125, ‘‘Issuance of Bulletin 2011–01, ‘‘Mitigating Strategies,’’ September 12, 2011 ... ML111250360.
SRM–COMSECY–13–0030, Staff Evaluation and Recommendation for Japan Lessons-Learned ML14143A360.
Tier 3 Issue on Expedited Transfer of Spent Fuel, May 23, 2014.
The Thompson Report, ‘‘New And Significant Information From The Fukushima Daiichi Acci- ML12094A183.
dent In The Context Of Future Operation Of The Pilgrim Nuclear Power Plant,’’ June 1, 2011.

Dated at Rockville, Maryland, this 25th day Rule, which requires that eyecare written data, views, and arguments
of August, 2015. prescribers provide a copy of a concerning the Rule.
For the Nuclear Regulatory Commission. consumer’s prescription to the DATES: Written comments must be
Annette L. Vietti-Cook, consumer upon completion of a contact received on or before October 26, 2015.
Secretary of the Commission. lens fitting and verify or provide
[FR Doc. 2015–21834 Filed 9–2–15; 8:45 am] prescriptions to authorized third parties. ADDRESSES: Interested parties may file a
comment at https://
BILLING CODE 7590–01–P The Rule also mandates that a contact
ftcpublic.commentworks.com/ftc/
lens seller may sell contact lenses only
contactlensrule online or on paper, by
in accordance with a prescription that
following the instructions in the
FEDERAL TRADE COMMISSION the seller either: (a) Has received from Instructions for Submitting Comments
the patient or prescriber; or (b) has part of the SUPPLEMENTARY INFORMATION
16 CFR Part 315 verified through direct communication section below. Write ‘‘Contact Lens
rmajette on DSK7SPTVN1PROD with PROPOSALS

with the prescriber. The Commission is Rule, 16 CFR part 315, Project No.
Contact Lens Rule soliciting comments about the R511995’’ on your comment, and file
AGENCY: Federal Trade Commission efficiency, costs, benefits, and your comment online at https://
(‘‘FTC’’ or ‘‘Commission’’). regulatory impact of the Rule as part of ftcpublic.commentworks.com/ftc/
ACTION: Request for comment.
its systematic review of all current contactlensrule by following the
Commission regulations and guides. All instructions on the web-based form. If
SUMMARY: The Commission is requesting interested persons are hereby given you prefer to file your comment on
public comments on the Contact Lens notice of the opportunity to submit paper, write ‘‘Contact Lens Rule, 16 CFR

VerDate Sep<11>2014 13:54 Sep 02, 2015 Jkt 235001 PO 00000 Frm 00008 Fmt 4702 Sfmt 4702 E:\FR\FM\03SEP1.SGM 03SEP1

Federal Register / Vol. 80, No. 171 / Thursday, September 3, 2015 / Proposed Rules 53273

part 315, Project No. R511995’’ on your by direct communication with the regulations; and the effect on the Rule
comment and on the envelope and mail prescriber.5 The Rule sets out the of any technological, economic, or other
your comment to the following address: information that must be included in a industry changes since the Rule was
Federal Trade Commission, Office of the seller’s verification request, and directs promulgated.
Secretary, 600 Pennsylvania Avenue that a prescription is only verified under
III. Issues for Comment
NW., Suite CC–5610 (Annex C), the Rule if: (1) A prescriber confirms the
Washington, DC 20580, or deliver your prescription is accurate, (2) a prescriber The Commission requests written
comment to the following address: informs the seller that the prescription comment on any or all of the following
Federal Trade Commission, Office of the is inaccurate and provides an accurate questions. These questions are designed
Secretary, Constitution Center, 400 7th prescription, or (3) if the prescriber fails to assist the public and should not be
Street SW., 5th Floor, Suite 5610 to communicate with the seller within construed as a limitation on the issues
(Annex C), Washington, DC 20024. eight business hours after receiving a on which public comment may be
FOR FURTHER INFORMATION CONTACT: compliant verification request.6 The submitted. The Commission requests
Alysa Bernstein, Attorney, (202) 326– Rule states that if the prescriber informs that responses to its questions be as
3289, or Bonnie McGregor, Federal the seller within eight hours of receiving specific as possible, including a
Trade Investigator, (202) 326–2356, the verification request that the reference to the question being
Division of Advertising Practices, prescription is inaccurate, expired, or answered, and reference to empirical
Bureau of Consumer Protection, Federal invalid, the seller shall not fill the data or other evidence upon which
Trade Commission, 600 Pennsylvania prescription.7 comments are based wherever available
Avenue NW., Washington, DC 20580. Sellers may not alter a prescription, and appropriate.
SUPPLEMENTARY INFORMATION: but for private label contact lenses, may 1. Is there a continuing need for the
substitute identical contact lenses that Rule? Why or why not?
I. Background the same company manufactures and 2. What benefits has the Rule
In 2003, Congress enacted The sells under a different name.8 Sellers provided to consumers? What evidence
Fairness to Contact Lens Consumers and others involved in the manufacture, supports the asserted benefits?
Act, 15 U.S.C. 7601–7610, and pursuant assembly, processing and distribution of 3. What modifications, if any, should
to the Act, the Commission promulgated contact lenses are prohibited from be made to the Rule to increase its
the Contact Lens Rule on July 2, 2004.1 representing that contact lenses may be benefits to consumers?
The Rule went into effect on August 2, obtained without a prescription.9 a. What evidence supports the
2004. The Contact Lens Rule sets a proposed modifications?
The Contact Lens Rule is intended to minimum expiration date of one year b. How would these modifications
facilitate the ability of consumers to after the issue date of a prescription affect the costs the Rule imposes on
comparison shop for contact lenses with an exception based on a patient’s businesses, including small businesses?
while ensuring that contact lenses are ocular health.10 The Rule also c. How would these modifications
sold only in accordance with a valid implements the Act by providing that affect the benefits to consumers?
prescription. The Rule requires that ‘‘state and local laws and regulations 4. What impact has the Rule had on
eyecare prescribers provide a copy of a that establish a prescription expiration the flow of truthful information to
prescription to the consumer upon date of less than one year or that restrict consumers and on the flow of deceptive
completion of a contact lens fitting and prescription release or require active information to consumers?
verify or provide prescriptions to verification are pre-empted.’’ 11 5. What significant costs, if any, has
authorized third parties.2 II. Regulatory Review of the Contact the Rule imposed on consumers? What
The Rule specifies that a prescriber Lens Rule evidence supports the asserted costs?
may not require the purchase of contact 6. What modifications, if any, should
lenses as a condition of providing the The Commission periodically reviews be made to the Rule to reduce any costs
prescription or verification, may not all of its rules and guides. These reviews imposed on consumers?
require payment in addition to, or as a seek information about the costs and a. What evidence supports the
part of, the fee for an eye examination, benefits of the agency’s rules and proposed modifications?
fitting, and evaluation as a condition of guides, and their regulatory and b. How would these modifications
providing the prescription or economic impact. The information affect the benefits provided by the Rule?
verification, and may not require the obtained assists the Commission in 7. What benefits, if any, has the Rule
patient to sign a waiver or release as a identifying those rules and guides that provided to businesses, including small
condition of releasing or verifying the warrant modification or rescission. businesses? What evidence supports the
Therefore, the Commission solicits asserted benefits?
prescription.3 The prescriber is also
comments on, among other things, the 8. What modifications, if any, should
prohibited from requiring immediate
economic impact and benefits of the be made to the Rule to increase its
payment before the release of a
Rule; possible conflict between the Rule benefits to businesses, including small
prescription, unless the prescriber
and State, local, or other Federal laws or businesses?
requires immediate payment when an
exam reveals that the consumer does not a. What evidence supports the
5 16 CFR 315.5(a).
need ophthalmic goods.4 proposed modifications?
6 16 CFR 315.5(b)–(c).
The Rule also places certain 7 16 CFR 315.5(d). If the prescription
b. How would these modifications
restrictions on sellers. It mandates that affect the costs the Rule imposes on
rmajette on DSK7SPTVN1PROD with PROPOSALS

communicated by the seller is inaccurate, the
sellers sell contact lenses only in prescriber shall correct it. Id. businesses, including small businesses?
accordance with a prescription that is 8 16 CFR 315.5(e). c. How would these modifications
either presented to the seller or verified
9 16 CFR 315.7. affect the benefits to consumers?
10 16 CFR 315.6.
9. What significant costs, if any,
11 16 CFR 315.11(a). The Rule states further that
1 ContactLens Rule, 16 CFR part 315. including costs of compliance, has the
‘‘[a]ny other state or local laws or regulations that
2 16 CFR 315.3(a). are inconsistent with the Act or this part are
Rule imposed on businesses, including
3 16 CFR 315.3(b).
prempted to the extent of the inconsistency.’’ 16 small businesses? What evidence
4 16 CFR 315.4. CFR 315.11(b). supports the asserted costs?

VerDate Sep<11>2014 13:54 Sep 02, 2015 Jkt 235001 PO 00000 Frm 00009 Fmt 4702 Sfmt 4702 E:\FR\FM\03SEP1.SGM 03SEP1

Document Created: 2015-12-15 09:56:43
Document Modified: 2015-12-15 09:56:43

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Proposed Rules
Action		Request for comment.
Dates		Written comments must be received on or before October 26, 2015.
Contact		Alysa Bernstein, Attorney, (202) 326- 3289, or Bonnie McGregor, Federal Trade Investigator, (202) 326-2356, Division of Advertising Practices, Bureau of Consumer Protection, Federal Trade Commission, 600 Pennsylvania Avenue NW., Washington, DC 20580.
FR Citation		80 FR 53272